At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BHST BIOHARVEST SCIENCES INC
Post-Mkt 05-19 19:15:37 EDT
3.92
-0.04
-1.01%
盘后3.92
+0.000.00%
16:04 EDT
High4.05Low3.91Vol14.55K
Open4.00D1 Closing3.96Amplitude3.48%
Mkt Cap88.80MTradable Cap69.84MTotal Shares22.65M
T/O57.69KT/O Rate0.08%Tradable Shares17.82M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Tate & Lyle expands BioHarvest collaboration on plant-based sweetener molecules
Reuters  ·  05-18 17:09
Tate & Lyle expands BioHarvest collaboration on plant-based sweetener molecules
Analysts Offer Insights on Consumer Goods Companies: Walmart (WMT) and BioHarvest Sciences (BHST)
TIPRANKS  ·  05-15
Analysts Offer Insights on Consumer Goods Companies: Walmart (WMT) and BioHarvest Sciences (BHST)
Craig-Hallum Sticks to Their Buy Rating for BioHarvest Sciences (BHST)
TIPRANKS  ·  05-15
Craig-Hallum Sticks to Their Buy Rating for BioHarvest Sciences (BHST)
BioHarvest Sciences Q1 EPS $(0.11) Beats $(0.12) Estimate, Sales $8.500M Miss $8.796M Estimate
Benzinga  ·  05-14
BioHarvest Sciences Q1 EPS $(0.11) Beats $(0.12) Estimate, Sales $8.500M Miss $8.796M Estimate
Calendar of U.S. Earnings Expected in the Week Ahead
Dow Jones  ·  05-13
Calendar of U.S. Earnings Expected in the Week Ahead
Bioharvest Sciences Inc: CDMO Division Signed $1.2 Million-Dollar Stage 2 Contract
THOMSON REUTERS  ·  05-13
Bioharvest Sciences Inc: CDMO Division Signed $1.2 Million-Dollar Stage 2 Contract
BioHarvest signs $1.2 million Stage 2 CDMO contract for rare fragrance development
Reuters  ·  05-12
BioHarvest signs $1.2 million Stage 2 CDMO contract for rare fragrance development
BioHarvest names co-founder Zaki Rakib CEO in leadership transition
Reuters  ·  05-12
BioHarvest names co-founder Zaki Rakib CEO in leadership transition
BioHarvest Sciences publishes investor presentation on Botanical Synthesis plant-cell compound production
Reuters  ·  05-05
BioHarvest Sciences publishes investor presentation on Botanical Synthesis plant-cell compound production
BioHarvest Sciences to report Q1 2026 results, host earnings call
Reuters  ·  05-01
BioHarvest Sciences to report Q1 2026 results, host earnings call
Bioharvest Sciences Inc: Announces Zaki Rakib, Co-Founder and Executive Chairman, Assumes Role of CEO
THOMSON REUTERS  ·  04-30
Bioharvest Sciences Inc: Announces Zaki Rakib, Co-Founder and Executive Chairman, Assumes Role of CEO
BioHarvest names co-founder Zaki Rakib CEO, Ilan Sobel joins board
Reuters  ·  04-29
BioHarvest names co-founder Zaki Rakib CEO, Ilan Sobel joins board
April 2026's Top 3 Stocks That May Be Trading Below Estimated Fair Value
Simply Wall St.  ·  04-28
April 2026's Top 3 Stocks That May Be Trading Below Estimated Fair Value
3 Stocks That Might Be Undervalued By Up To 48.3% Offering A Possible Discount
Simply Wall St.  ·  04-25
3 Stocks That Might Be Undervalued By Up To 48.3% Offering A Possible Discount
3 Stocks Including Impinj That May Be Trading Below Their Estimated Value
Simply Wall St.  ·  04-21
3 Stocks Including Impinj That May Be Trading Below Their Estimated Value
Hamilton Lane And 2 Additional Stocks Possibly Priced Below Their Estimated Value
Simply Wall St.  ·  04-17
Hamilton Lane And 2 Additional Stocks Possibly Priced Below Their Estimated Value
Roth MKM Keeps Their Buy Rating on BioHarvest Sciences (BHST)
TIPRANKS  ·  04-06
Roth MKM Keeps Their Buy Rating on BioHarvest Sciences (BHST)
BioHarvest FY25 net loss narrows to $11.1 million; revenue climbs 37% to $34.5 million
Reuters  ·  04-01
BioHarvest FY25 net loss narrows to $11.1 million; revenue climbs 37% to $34.5 million
BioHarvest develops stable cell culture for rare fragrance plant, completing Stage 1 program
Reuters  ·  04-01
BioHarvest develops stable cell culture for rare fragrance plant, completing Stage 1 program
BioHarvest Sciences Inc. - Common Stock Q4 EPS $(0.10), Inline, Sales $9.100M Miss $9.279M Estimate
Benzinga  ·  04-01
BioHarvest Sciences Inc. - Common Stock Q4 EPS $(0.10), Inline, Sales $9.100M Miss $9.279M Estimate

Introduction

Company Name.
BIOHARVEST SCIENCES INC
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. It engages in research and development of science based therapeutic solutions for the nutraceutical industry; and plant cell-based active pharmaceutical ingredients that can assist in the treatment of specific medical indications The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product; and medical cannabis. BioHarvest Sciences Inc. is based in Vancouver, Canada.
Issue price:
--